Shield Therapeutics (STX)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

2.95p
   
  • Change Today:
      0.28p
  • 52 Week High: 7.65p
  • 52 Week Low: 1.23p
  • Currency: UK Pounds
  • Shares Issued: 782.06m
  • Volume: 40,674,235
  • Market Cap: £23.07m
  • Beta: 1.88

Latest ShareCast News

Shield Therapeutics reports strong quarter for Accrufer

By Josh White

Date: Tuesday 29 Oct 2024

(Sharecast News) - Shield Therapeutics reported a strong third-quarter performance for its iron deficiency treatment Accrufer in the US on Tuesday, achieving net revenue of $7.2m.

Shield Therapeutics announces promising paediatric trial results

By Josh White

Date: Wednesday 25 Sep 2024

(Sharecast News) - Shield Therapeutics announced promising results from its phase three paediatric clinical trial for 'Accrufer' and 'Ferracru', or ferric maltol, in treating iron deficiency anaemia (IDA) in children on Wednesday.

Shield Therapeutics iron deficiency treatment approved in Canada

By Josh White

Date: Tuesday 27 Aug 2024

(Sharecast News) - Commercial-stage pharmaceutical company Shield Therapeutics announced on Tuesday that 'ACCRUFeR', or ferric maltol, had been approved by Health Canada as a prescription drug for the treatment of adults with iron deficiency anaemia (IDA).

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

STX Market Data

Currency UK Pounds
Share Price 2.95p
Change Today 0.28p
% Change 10.28 %
52 Week High 7.65p
52 Week Low 1.23p
Volume 40,674,235
Shares Issued 782.06m
Market Cap £23.07m
Beta 1.88

STX Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
34.63% below the market average34.63% below the market average34.63% below the market average34.63% below the market average34.63% below the market average
76.00% above the sector average76.00% above the sector average76.00% above the sector average76.00% above the sector average76.00% above the sector average
Price Trend
30.96% below the market average30.96% below the market average30.96% below the market average30.96% below the market average30.96% below the market average
14.29% below the sector average14.29% below the sector average14.29% below the sector average14.29% below the sector average14.29% below the sector average
Income Not Available
Growth
64.44% above the market average64.44% above the market average64.44% above the market average64.44% above the market average64.44% above the market average
70.59% above the sector average70.59% above the sector average70.59% above the sector average70.59% above the sector average70.59% above the sector average

What The Brokers Say

Strong Buy 0
Buy 0
Neutral 1
Sell 0
Strong Sell 0
Total 1
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

STX Dividends

No dividends found

Trades for 21-Nov-2024

Time Volume / Share Price
16:30 50,000 @ 2.95p
16:25 500,000 @ 3.23p
16:24 250,000 @ 2.90p
16:17 33,878 @ 2.94p
16:16 15,000 @ 2.94p

Top of Page